Advertisement
Screener

Bausch Health Companies Inc. (BHC) Material Contracts, 2020

Bausch Health Companies Inc. Material Contracts

Every material contract the company filed as Exhibit 10 (executive pay plans, credit agreements, supplier and indemnity agreements), newest first, with the filing's own description.

  • 2020-02-19: Form 10-K; Exhibit 10.30; Description Stipulation of Settlement dated December 15, 2019 in the U.S. Securities Litigation ††.
  • 2020-02-19: Form 10-K; Exhibit 10.1; Description Bausch Health Companies Inc. Amended and Restated 2014 Omnibus Incentive Plan, effective as of April 30, 2018 (the "Amended and Restated 2014 Omnibus Incentive Plan").†.
FiledFormExhibitDescription
2020-02-1910-K10.30Stipulation of Settlement dated December 15, 2019 in the U.S. Securities Litigation ††
2020-02-1910-K10.1Bausch Health Companies Inc. Amended and Restated 2014 Omnibus Incentive Plan, effective as of April 30, 2018 (the "Amended and Restated 2014 Omnibus Incentive Plan").†

Similar stocks

Stock NameCountryMarket CapPE Ratio
Braveheart Bio, Inc. (BRVE)United States$2.106B
PALVELLA THERAPEUTICS, INC. (PVLA)United States$2.105B-35.55
Trevi Therapeutics, Inc. (TRVI)United States$2.091B-51.93
OCULAR THERAPEUTIX, INC (OCUL)United States$2.159B-7.15
Prestige Consumer Healthcare Inc. (PBH)United States$2.163B13.03
Generate Biomedicines, Inc. (GENB)United States$2.052B
PERRIGO Co plc (PRGO)Ireland$2.038B-0.79
NEKTAR THERAPEUTICS (NKTR)United States$2.026B-9.05
Aurinia Pharmaceuticals Inc. (AUPH)$2.207B7.18
UroGen Pharma Ltd. (URGN)$2.015B-18.42